Wolverine Blend 5/5

$99.00

99%+ Purity

A pre-mixed research blend pairing Body Protection Compound 157 and TB — two complementary recovery peptides combining cytoprotective and actin-binding mechanisms for tissue-repair studies.

Verified test results

Batch and certificate of analysis

Current lot DPS-7021946 · 5 mg / 5 mg · tested July 18, 2026 · Horizon Analytical. The results below are from the certificate for this exact lot, not a representative sample.

ParameterResultMethodSpecification
Identity2-peptide blend · PassUPLC/MSConfirmed
AppearanceWhite lyophilized powderVisualMeets specification
Purity99.39% · PassUPLC/MSSpecification > 98%
Net content9.8 mgUPLC/MSLabeled 10 mg

Measured content by component

ComponentLabeledMeasuredPurity
Body Protection Compound 1575 mg4.9 mg99.39%
TB5 mg4.9 mg99.5%

Research specifications

FormLyophilised powder in a sealed glass vial
Labeled content5 mg / 5 mg
Appearance (current lot)White lyophilized powder
StorageSealed vials cold, dry and protected from light; frozen for long-term storage
Intended useLaboratory research only

Composition and identifiers

ComponentLabeledResiduesMolecular formulaMolecular weightCASPubChem
Body Protection Compound 1575mg15C62H98N16O221419.5 g/mol137525-51-09941957
TB5mg43C212H350N56O78S4963.0 g/molNot listed45382195

Identifiers are the values PubChem lists for the named record, checked September 2026. Where PubChem lists no CAS number, none is shown.

Identity, composition and analytical documentation

Each released lot is tested by an independent laboratory (Horizon Analytical for the current lot). The certificate reports identity by mass spectrometry, purity by UPLC/MS, and net content measured against the labeled amount, for each component of the blend. A separate endotoxin report accompanies the certificate for this lot. The certificate does not include heavy-metal, sterility, residual-solvent or microbial testing. The lot number on the certificate is the lot number on the vial, so a certificate can be matched to the material in hand. Certificates for every lot released on this site remain available on the COA page.

Research overview

Findings below are from the cited laboratory and animal studies; nothing here describes effects in people.

Research Overview

The Wolverine Blend combines two of the most studied tissue repair peptides — Body Protection Compound 157 and TB (Thymosin-B) — in a single pre-mixed formulation. This combination allows researchers to investigate the interplay between two distinct but complementary tissue repair mechanisms in a standardized preparation.

Body Protection Compound 157 is studied for its cytoprotective properties, nitric oxide signaling modulation, and growth factor pathway interactions. TB is investigated for its role in actin polymerization regulation, cell migration signaling, and cytoskeletal dynamics. The rationale for combining these peptides in research stems from their non-overlapping mechanisms: Body Protection Compound 157 primarily engages growth factor and inflammatory mediator pathways, while TB acts through actin-binding and sequestration mechanisms.

Researchers use this blend in comparative studies to examine whether concurrent exposure to both mechanisms produces additive or synergistic effects in tissue repair models, cell migration assays, and angiogenesis studies. The pre-mixed formulation eliminates preparation variability between the two components.

Laboratory applications include wound healing models, musculoskeletal tissue culture studies, inflammatory response profiling, and concentration-response characterization across multiple tissue types. The blend is supplied as lyophilized powder requiring reconstitution with bacteriostatic water.

Explore the PeptidesATX Research Library for additional peptide pharmacology guides and reference resources.

Wolverine blend compared with its two components

Rows describe composition and documentation, not effects.

Wolverine Blend 5/5Body Protection Compound 157TB
CompositionBody Protection Compound 157 5 mg + TB 5 mgSingle compoundSingle compound (in blends only on this site)
When it is chosenModels that call for both peptides in one preparationModels that isolate one mechanism—
Certificate of analysisPer-component measured contentSingle-compound purity and identityReported within blend certificates

Scientific references

  1. Sikiric P, et al. Curr Neuropharmacol. 2016;14(8):857–865. PubMed 27138887
  2. Goldstein AL, Hannappel E, Kleinman HK. Trends Mol Med. 2005;11(9):421–429. PubMed 16099219
  3. Malinda KM, et al. J Invest Dermatol. 1999;113(3):364–368. PubMed 10469335

Related research guides

Frequently asked questions

Which lot will I receive, and how do I check it?
The lot shown on this page (DPS-7021946) is the one currently shipping; when a new lot is released, this page and the COA page update together. The lot number is printed on the vial label and matches the certificate.
What does the certificate of analysis cover?
Identity and purity by UPLC/MS from an independent laboratory (Horizon Analytical), measured net content against the labeled amount, measured content of each component, and appearance, with a separate endotoxin report; both documents are linked above as PDFs. The certificate does not include heavy-metal, sterility, residual-solvent or microbial testing.
How is a blend documented?
The certificate reports each component separately: the amount measured against the amount labeled, and the purity of the blend as tested. A single purity figure without the per-component breakdown would not tell you what the vial contains.
How should the vial be stored on receipt?
Sealed lyophilised vials are kept cold, dry and away from light; long-term storage is frozen. The handling notes on this page and the storage guide give the laboratory practice in more detail.
When does an order ship?
Orders placed before the daily cutoff shown above ship the same business day from Austin, Texas, with tracking. Delivery estimates and the free-shipping threshold are shown in the order summary.